4
Changes in Ownership
Protagenic Therapeutics, Inc.\new Filed Acc 0001493152-21-013279
Options or other derivatives
- Chief Financial Officer bought 3,000 shares at $0.38 ($1,140)
From the SEC's structured data for this filing
Trades in this filing
Arrow Alexander K. · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-27 | Purchase : show line 1 in the form PTIXW Common Stock 5-year warrants strike price $4.98 | +3,000 | $0.38 | $1,140 | 33,000 | D |
Loading xslF345X03/ownership.xml…